Show an ad over header. AMP

I am the FIRST!!!

Where the Trump campaign's war chest of over $1 billion went

Sep. 08, 2020 12:23PM EST
Dan Ackermann
Lead story of today's New York Times

In a deeply reported article on "How Trump's Billion-Dollar Campaign Lost Its Cash Advantage," the N.Y. Times' Shane Goldmacher and Maggie Haberman found some unusual spending by the Trump campaign.

Why it matters: Money concerns are very real for President Trump's campaign — an unusual predicament for a sitting president, and one that worries veteran Republican operatives.

Details:

  • "Super Bowl ads that cost $11 million."
  • "$156,000 for planes to pull aerial banners in recent months."
  • "Nearly $110,000 to Yondr, a company that makes magnetic pouches used to store cellphones during fundraisers so that donors could not secretly record Trump and leak his remarks."
  • "[M]ore than $1 million in ads aired in the Washington, D.C., media market," which the Times characterizes as a "Trump-pleasing expense."
  • "[A]bout $4 million into the Trump family businesses since 2019."
  • "Hershey Company, the chocolate-maker ($337,000), which cover costs for items such as the White House-branded M&Ms given away by administrations of both parties."
  • Former campaign manager Brad Parscale "had a car and driver, an unusual expense for a campaign manager."

Keep reading (subscription).

regular 4 post ff

infinite scroll 4 pff

Biden: "We can't wait any longer to deal with climate crisis"

President Biden urged immediate actions on climate change on Wednesday, saying "[w]e can't wait any longer to deal with climate crisis" during an event promoting his Build Back Better agenda

Driving the news: The U.S. is currently facing an extreme heat wave and heavy wildfires in the West, a deadly drought and the the earliest fifth-named Atlantic tropical storm on record currently going through the Southeast.

Keep reading...Show less

FDA calls for independent review of Alzheimer's drug approval

FDA Acting Commissioner Janet Woodcock on Friday formally asked the HHS' Office of Inspector General to "conduct an independent review and assessment of interactions between representatives of Biogen and FDA during the process that led to the approval of Aduhelm."

Why it matters: Aduhelm has been one of the most controversial drug approvals in recent memory. The rare move from the agency comes on the heels of a STAT News report that detailed how Biogen and FDA officials worked closely during the process, and possibly violated FDA rules with an "off-the-books" meeting.

G20 leaders back global tax deal

Finance ministers from the world's 20 largest economies backed a proposal on Saturday that seeks to introduce an international tax on multinational companies and sets a global minimum tax rate of 15%, Politico reports.

Why it matters: If enacted, the reform could alter who gets to tax multinational corporations and "stop multinationals from shifting profits into tax havens," Politico reports.

Keep reading...Show less
Insights

Insights

Test after compact

test test

fsgasg asfdasf

Hello 2

mail-copy

Get Goodhumans in your inbox

Most Read

Most Read

test test

fsgasg asfdasf

Hello 2

Hello there

Here is my another X post

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;